Entera Bio Ltd. ENTX and OPKO Health, Inc. OPK recently announced positive topline pharmacokinetic/pharmacodynamic (PK/PD) results from their ongoing collaborative ...
OPKO Health, Inc. OPK posted earnings per share of 3 cents for the third quarter of 2025, flat year over year. Earnings beat the Zacks Consensus Estimate of a loss of 2 cents per share by 250.00%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback